戻る
Antengene Corporation Limited (06996.HK)価格
06996.HK 株価推移チャート
ANTENGENE-B (06996.HK)
Antengene Corporation Limited
HK$3.6
-1.09%
$-0.04
休場: Jan 21, 16:00:00 HKT
主要データ
前終値
$3.7
始値
$3.64
当日レンジ
$3.54 - $3.68
52週レンジ
$0.69 - $8.16
取引高
2.5M
平均取引高
2.4M
1株当たり利益(TTM)
-0.40
配当利回り
--
時価総額
$2.1B
ANTENGENE-Bとは何ですか？
Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 152 full-time employees. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The firm's products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.
